Towards a point-of-care test for active tuberculosis: obstacles and opportunities (original) (raw)

• WHO. Global tuberculosis control: WHO Report 2010 (WHO, Geneva, 2010).
• WHO. Global tuberculosis control: surveillance, planning, financing (WHO, Geneva, 2009).
• Fox, W., Ellard, G. A. & Mitchison, D. A. Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946–1986, with relevant subsequent publications. Int. J. Tuberc. Lung Dis. 3, S231–S279 (1999).
  CAS PubMed Google Scholar
• Lienhardt, C. et al. Factors affecting time delay to treatment in a tuberculosis control programme in a sub-Saharan African country: the experience of The Gambia. Int. J. Tuberc. Lung Dis. 5, 233–239 (2001).
  CAS PubMed Google Scholar
• Golub, J. E. et al. Delayed tuberculosis diagnosis and tuberculosis transmission. Int. J. Tuberc. Lung Dis. 10, 24–30 (2006).
  CAS PubMed Google Scholar
• Rajeswari, R. et al. Factors associated with patient and health system delays in the diagnosis of tuberculosis in South India. Int. J. Tuberc. Lung Dis. 6, 789–795 (2002).
  CAS PubMed Google Scholar
• Salaniponi, F. M. et al. Care seeking behaviour and diagnostic processes in patients with smear-positive pulmonary tuberculosis in Malawi. Int. J. Tuberc. Lung Dis. 4, 327–332 (2000).
  CAS PubMed Google Scholar
• Storla, D. G., Yimer, S. & Bjune, G. A. A systematic review of delay in the diagnosis and treatment of tuberculosis. BMC Public Health 8, 15 (2008). This article reviews the factors contributing to the delayed detection of TB and to the subsequent failure of patients to access treatment, all of which are current major obstacles to controlling the disease.
  Article PubMed PubMed Central Google Scholar
• Lonnroth, K., Thuong, L. M., Linh, P. D. & Diwan, V. K. Delay and discontinuity—a survey of TB patients' search of a diagnosis in a diversified health care system. Int. J. Tuberc. Lung Dis. 3, 992–1000 (1999).
  CAS PubMed Google Scholar
• Keeler, E. et al. Reducing the global burden of tuberculosis: the contribution of improved diagnostics. Nature 444 (Suppl. 1), 49–57 (2006). The authors estimate the potential global impact of better TB tests by using a decision tree model to simulate the introduction of improved tests for adult pulmonary patients.
  Article PubMed Google Scholar
• McNerney, R. Symposium: Point-of-care tests for tuberculosis. Rev. Port. Pneumol. 16, 49–55 (2010).
  Article Google Scholar
• Foulds, J. & O'Brien, R. New tools for the diagnosis of tuberculosis: the perspective of developing countries. Int. J. Tuberc. Lung Dis. 2, 778–783 (1998).
  CAS PubMed Google Scholar
• Steingart, K. R., Ramsay, A. & Pai, M. Optimizing sputum smear microscopy for the diagnosis of pulmonary tuberculosis. Expert Rev. Anti Infect. Ther. 5, 327–331 (2007).
  Article PubMed Google Scholar
• Elliott, A. M. et al. Impact of HIV on tuberculosis in Zambia: a cross sectional study. BMJ 301, 412–415 (1990).
  Article CAS PubMed PubMed Central Google Scholar
• Golden, M. P. & Vikram, H. R. Extrapulmonary tuberculosis: an overview. Am. Fam. Physician 72, 1761–1768 (2005).
  PubMed Google Scholar
• Perkins, M. D. & Kritski, A. L. Diagnostic testing in the control of tuberculosis. Bull. World Health Organ. 80, 512–513 (2002).
  PubMed PubMed Central Google Scholar
• Steingart, K. R. et al. Commercial serological antibody detection tests for the diagnosis of pulmonary tuberculosis: a systematic review. PLoS Med. 4, e202 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Lemaire, J. F. & Casenghi, M. New diagnostics for tuberculosis: fulfilling patient needs first. J. Int. AIDS Soc. 13, 40 (2010). This article discusses the desired specifications for new TB tests that will improve access to treatment for patients in resource-limited settings.
  Article PubMed PubMed Central Google Scholar
• Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 69, 89–95 (2001).
• Doherty, M., Wallis, R. S. & Zumla, A. Biomarkers for tuberculosis disease status and diagnosis. Curr. Opin. Pulm. Med. 15, 181–187 (2009).
  Article PubMed Google Scholar
• Parida, S. K. & Kaufmann, S. H. The quest for biomarkers in tuberculosis. Drug Discov. Today 15, 148–157 (2010).
  Article CAS PubMed Google Scholar
• Jacobsen, M., Mattow, J., Repsilber, D. & Kaufmann, S. H. Novel strategies to identify biomarkers in tuberculosis. Biol. Chem. 389, 487–495 (2008). The identification of improved biomarkers is a research priority, and this article describes the application of new technologies such as bioinformatics, transcriptomics, proteomics, metabolomics and lipidomics to TB biomarker discovery.
  Article CAS PubMed Google Scholar
• Wallis, R. S. et al. Biomarkers for tuberculosis disease activity, cure, and relapse. Lancet Infect. Dis. 10, 68–69 (2010).
  Article PubMed Google Scholar
• Steingart, K. R. et al. Performance of purified antigens for serodiagnosis of pulmonary tuberculosis: a meta-analysis. Clin. Vaccine Immunol. 16, 260–276 (2009).
  Article CAS PubMed Google Scholar
• Abebe, F. C., Holm-Hansen, C., Wiker, H. G. & Bjune, G. Progress in serodiagnosis of Mycobacterium tuberculosis infection. Scand. J. Infect. Dis. 66, 176–191 (2007).
  CAS Google Scholar
• Special Programme for Research & Training in Tropical Diseases. Laboratory-based evaluation of 19 commercially available rapid diagnostic tests for tuberculosis (WHO, Geneva, 2008). This report presents the results from a project evaluating rapid TB tests, and demonstrates the need for improved evaluation and regulation to discourage the marketing of substandard tests.
• Beyene, D. et al. Serodiagnosis of tuberculous lymphadenitis using a combination of antigens. J. Infect. Dev. Ctries 4, 96–102 (2010).
  Article CAS PubMed Google Scholar
• Zhang, S. L. et al. Development and evaluation of a novel multiple-antigen ELISA for serodiagnosis of tuberculosis. Tuberculosis (Edinb.) 89, 278–284 (2009).
  Article CAS Google Scholar
• Kunnath-Velayudhan, S. et al. Dynamic antibody responses to the Mycobacterium tuberculosis proteome. Proc. Natl Acad. Sci. USA 107, 14703–14708 (2010).
  Article PubMed PubMed Central Google Scholar
• Davies, D. H. et al. Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery. Proc. Natl Acad. Sci. USA 102, 547–552 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Li, Y. et al. A proteome-scale identification of novel antigenic proteins in Mycobacterium tuberculosis toward diagnostic and vaccine development. J. Proteome Res. 9, 4812–4822 (2010).
  Article CAS PubMed Google Scholar
• Weldingh, K., Rosenkrands, I., Okkels, L. M., Doherty, T. M. & Andersen, P. Assessing the serodiagnostic potential of 35 Mycobacterium tuberculosis proteins and identification of four novel serological antigens. J. Clin. Microbiol. 43, 57–65 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Bahk, Y. Y. et al. Antigens secreted from Mycobacterium tuberculosis: identification by proteomics approach and test for diagnostic marker. Proteomics 4, 3299–3307 (2004).
  Article CAS PubMed Google Scholar
• Sartain, M. J., Slayden, R. A., Singh, K. K., Laal, S. & Belisle, J. T. Disease state differentiation and identification of tuberculosis biomarkers via native antigen array profiling. Mol. Cell Proteomics 5, 2102–2113 (2006).
  Article CAS PubMed Google Scholar
• Agranoff, D. et al. Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum. Lancet 368, 1012–1021 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Berry, M. P. et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466, 973–977 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Palomino, J. C., Cardoso Leao, S. & Ritacco, V. Tuberculosis 2007: from basic science to patient care. Tuberculosis Textbook [online] (2007).
  Google Scholar
• Flores, L. L., Pai, M., Colford, J. M. Jr & Riley, L. W. In-house nucleic acid amplification tests for the detection of Mycobacterium tuberculosis in sputum specimens: meta-analysis and meta-regression. BMC Microbiol. 5, 55 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Telenti, A. et al. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 341, 647–650 (1993).
  Article CAS PubMed Google Scholar
• Traore, H., Fissette, K., Bastian, I., Devleeschouwer, M. & Portaels, F. Detection of rifampicin resistance in Mycobacterium tuberculosis isolates from diverse countries by a commercial line probe assay as an initial indicator of multidrug resistance. Int. J. Tuberc. Lung Dis. 4, 481–484 (2000).
  CAS PubMed Google Scholar
• Temple, B. et al. Rate and amplification of drug resistance among previously-treated patients with tuberculosis in Kampala, Uganda. Clin. Infect. Dis. 47, 1126–1134 (2008).
  Article PubMed Google Scholar
• Zager, E. M. & McNerney, R. Multidrug-resistant tuberculosis. BMC Infect. Dis. 8, 10 (2008).
  Article PubMed PubMed Central Google Scholar
• Daniel, T. M. Antibody and antigen detection for the immunodiagnosis of tuberculosis: why not? What more is needed? Where do we stand today? J. Infect. Dis. 158, 678–680 (1988).
  Article CAS PubMed Google Scholar
• Chatterjee, D., Bozic, C. M., McNeil, M. & Brennan, P. J. Structural features of the arabinan component of the lipoarabinomannan of Mycobacterium tuberculosis. J. Biol. Chem. 266, 9652–9660 (1991).
  CAS PubMed Google Scholar
• Dheda, K. et al. Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples. PLoS ONE 5, e9848 (2010). This article describes a potential application of a POC urine test to detect TB in HIV-positive patients, but also demonstrates the low sensitivity of the test in the general population; the exploratory use of this test in analysis of sputum samples shows a poor specificity.
  Article CAS PubMed PubMed Central Google Scholar
• Patel, V. B. et al. Utility of a novel lipoarabinomannan assay for the diagnosis of tuberculous meningitis in a resource-poor high-HIV prevalence setting. Cerebrospinal Fluid Res. 6, 13 (2009).
  Google Scholar
• Boehme, C. et al. Detection of mycobacterial lipoarabinomannan with an antigen-capture ELISA in unprocessed urine of Tanzanian patients with suspected tuberculosis. Trans. R. Soc. Trop. Med. Hyg. 99, 893–900 (2005).
  Article CAS PubMed Google Scholar
• Mutetwa, R. et al. Diagnostic accuracy of commercial urinary lipoarabinomannan detection in African tuberculosis suspects and patients. Int. J. Tuberc. Lung Dis. 13, 1253–1259 (2009).
  CAS PubMed Google Scholar
• Daley, P. et al. Blinded evaluation of commercial urinary lipoarabinomannan for active tuberculosis: a pilot study. Int. J. Tuberc. Lung Dis. 13, 989–995 (2009).
  CAS PubMed Google Scholar
• Shah, M. et al. Diagnostic accuracy of a urine lipoarabinomannan test for tuberculosis in hospitalized patients in a High HIV prevalence setting. J. Acquir. Immune Defic. Syndr. 52, 145–151 (2009).
  Article PubMed PubMed Central Google Scholar
• Lawn, S. D. et al. Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease. AIDS 23, 1875–1880 (2009).
  Article PubMed Google Scholar
• Wishart, D. S. et al. HMDB: the Human Metabolome Database. Nucleic Acids Res. 35, D521–D526 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Beste, D. J. et al. GSMN-TB: a web-based genome-scale network model of Mycobacterium tuberculosis metabolism. Genome Biol. 8, R89 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Hippocrates. Aphorisms (translation by Adams, F.) (Dodo Press, Gloucester, UK, 2009).
• Weetjens, B. J. et al. African pouched rats for the detection of pulmonary tuberculosis in sputum samples. Int. J. Tuberc. Lung Dis. 13, 737–743 (2009).
  PubMed Google Scholar
• Syhre, M. & Chambers, S. T. The scent of Mycobacterium tuberculosis. Tuberculosis (Edinb.) 88, 317–323 (2008).
  Article CAS Google Scholar
• Spooner, A. D., Bessant, C., Turner, C., Knobloch, H. & Chambers, M. Evaluation of a combination of SIFT-MS and multivariate data analysis for the diagnosis of Mycobacterium bovis in wild badgers. Analyst 134, 1922–1927 (2009).
  Article CAS PubMed Google Scholar
• Phillips, M. et al. Breath biomarkers of active pulmonary tuberculosis. Tuberculosis (Edinb.) 90, 145–151 (2010).
  Article CAS Google Scholar
• Syhre, M., Manning, L., Phuanukoonnon, S., Harino, P. & Chambers, S. T. The scent of Mycobacterium tuberculosis – Part II breath. Tuberculosis (Edinb.) 89, 263–266 (2009).
  Article CAS Google Scholar
• Fend, R. et al. Prospects for clinical application of electronic-nose technology to early detection of Mycobacterium tuberculosis in culture and sputum. J. Clin. Microbiol. 44, 2039–2045 (2006).
  Article PubMed PubMed Central Google Scholar
• Fend, R. et al. Use of an electronic nose to diagnose Mycobacterium bovis infection in badgers and cattle. J. Clin. Microbiol. 43, 1745–1751 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Knobloch, H., Turner, C., Spooner, A. & Chambers, M. Methodological variability using electronic nose technology for headspace analysis. AIP Conf. Proc. 1137, 327–330 (2009).
  Article CAS Google Scholar
• Knobloch, H., Turner, C., Spooner, A. & Chambers, M. Methodological variation in headspace analysis of liquid samples using electronic nose. Sens. Actuators B Chem. 139, 353–360 (2009).
  Article CAS Google Scholar
• Kolk, A. et al. Electronic-nose technology in diagnosis of TB patients using sputum samples. J. Clin. Microbiol. 48, 4235–4238 (2010).
  Article PubMed PubMed Central Google Scholar
• Phillips, M. et al. Volatile biomarkers of pulmonary tuberculosis in the breath. Tuberculosis (Edinb.) 87, 44–52 (2007).
  Article CAS Google Scholar
• Weigl, B., Domingo, G., Labarre, P. & Gerlach, J. Towards non- and minimally instrumented, microfluidics-based diagnostic devices. Lab Chip 8, 1999–2014 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Ikada, Y. & Tsuji, H. Biodegradable polyesters for medical and ecological applications. Macromol. Rapid Commun. 21, 117–132 (2000).
  Article CAS Google Scholar
• Poller, R. C. Reclamation of waste plastics and rubber: recovery of materials and energy. J. Chem. Technol. Biotechnol. 30, 152–160 (1980).
  Article CAS Google Scholar
• Helb, D. et al. Rapid detection of Mycobacterium tuberculosis and rifampin-resistance using on-demand, near patient technology. J. Clin. Microbiol. 48, 229–237 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Banada, P. P. et al. Containment of bioaerosol infection risk by the Xpert MTB/RIF assay and its applicability to point-of-care settings. J. Clin. Microbiol. 48, 3551–3557 (2010).
  Article PubMed PubMed Central Google Scholar
• Blakemore, R. et al. Evaluation of the analytical performance of the Xpert MTB/RIF assay. J. Clin. Microbiol. 48, 2495–2501 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Boehme, C. C. et al. Rapid molecular detection of tuberculosis and rifampin resistance. N. Engl. J. Med. 363, 1005–1015 (2010). This article by the test developers and their collaborators presents data on the performance of the Xpert ™ MTB/RIF assay, a laboratory- or clinic-based test that diagnoses TB, detects rifampicin resistance, requires little training and provides a result in under 2 hours.
  Article CAS PubMed PubMed Central Google Scholar
• Van Ness, J., Van Ness, L. K. & Galas, D. J. Isothermal reactions for the amplification of oligonucleotides. Proc. Natl Acad. Sci. USA 100, 4504–4509 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Notomi, T. et al. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res. 28, E63 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Fang, R. et al. Cross-priming amplification for rapid detection of Mycobacterium tuberculosis in sputum specimens. J. Clin. Microbiol. 47, 845–847 (2009).
  Article CAS PubMed Google Scholar
• Piepenburg, O., Williams, C. H., Stemple, D. L. & Armes, N. A. DNA detection using recombination proteins. PLoS Biol. 4, e204 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Soo, P. C. et al. A simple gold nanoparticle probes assay for identification of Mycobacterium tuberculosis and Mycobacterium tuberculosis complex from clinical specimens. Mol. Cell. Probes 23, 240–246 (2009).
  Article CAS PubMed Google Scholar
• Tan, E. et al. Isothermal DNA amplification coupled with DNA nanosphere-based colorimetric detection. Anal. Chem. 77, 7984–7992 (2005).
  Article CAS PubMed Google Scholar
• Mori, Y., Nagamine, K., Tomita, N. & Notomi, T. Detection of loop-mediated isothermal amplification reaction by turbidity derived from magnesium pyrophosphate formation. Biochem. Biophys. Res. Commun. 289, 150–154 (2001).
  Article CAS PubMed Google Scholar
• Boehme, C. C. et al. Operational feasibility of using loop-mediated isothermal amplification for diagnosis of pulmonary tuberculosis in microscopy centers of developing countries. J. Clin. Microbiol. 45, 1936–1940 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Lutz, S. et al. Microfluidic lab-on-a-foil for nucleic acid analysis based on isothermal recombinase polymerase amplification (RPA). Lab Chip 10, 887–893 (2010).
  Article CAS PubMed Google Scholar
• Hanlon, E. B. et al. Prospects for in vivo Raman spectroscopy. Phys. Med. Biol. 45, R1–R59 (2000).
  Article CAS PubMed Google Scholar
• Ozaki, Y., Cho, R., Ikegaya, K., Muraishi, S. & Kawauchi, K. Potential of near-infrared Fourier-transform Raman-spectroscopy in food analysis. Appl. Spectrosc. 46, 1503–1507 (1992).
  Article CAS Google Scholar
• Buijtels, P. C. et al. Rapid identification of mycobacteria by Raman spectroscopy. J. Clin. Microbiol. 46, 961–965 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• McNerney, R. et al. Field test of a novel detection device for Mycobacterium tuberculosis antigen in cough. BMC Infect. Dis. 10, 161 (2010).
  Article PubMed PubMed Central Google Scholar
• Liu, G. et al. Disposable electrochemical immunosensor diagnosis device based on nanoparticle probe and immunochromatographic strip. Anal. Chem. 79, 7644–7653 (2007).
  Article CAS PubMed Google Scholar
• Vo-Dinh, T., Cullum, B. M. & Stokes, D. L. Nanosensors and biochips: frontiers in biomolecular diagnostics. Sens. Actuator B Chem. 74, 2–11 (2001).
  Article CAS Google Scholar
• Jiang, X. H., Liu, W. Q., Chen, J. J. & Lin, X. Q. Application of DNA nanotechnology. Prog. Chem. 19, 608–613 (2007).
  CAS Google Scholar
• Qin, D. et al. Fluorescent nanoparticle-based indirect immunofluorescence microscopy for detection of Mycobacterium tuberculosis. J. Biomed. Biotechnol. 2007, 89364 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Yager, P. et al. Microfluidic diagnostic technologies for global public health. Nature 442, 412–418 (2006).
  Article CAS PubMed Google Scholar
• Baptista, P. V., Koziol-Montewka, M., Paluch-Oles, J., Doria, G. & Franco, R. Gold-nanoparticle-probe-based assay for rapid and direct detection of Mycobacterium tuberculosis DNA in clinical samples. Clin. Chem. 52, 1433–1434 (2006).
  Article CAS PubMed Google Scholar
• Lee, H., Sun, E., Ham, D. & Weissleder, R. Chip–NMR biosensor for detection and molecular analysis of cells. Nature Med. 14, 869–874 (2008).
  Article CAS PubMed Google Scholar
• Chun, A. L. Nanoparticles offer hope for TB detection. Nature Nanotech. 4, 698–699 (2009).
  Article CAS Google Scholar
• Harrington, M, Morgan, S. & Syed, J. 2009 Report on Tuberculosis Research Funding Trends, 2005–2008 2nd edn (Treatment Action Group, New York, 2010).
  Google Scholar
• Peeling, R. W. & Mabey, D. Point-of-care tests for diagnosing infections in the developing world. Clin. Microbiol. Infect. 16, 1062–1069 (2010). This article discusses the advantages of POC diagnostics for infectious diseases, and the potential of such tests to reduce morbidity and mortality in developing countries.
  Article CAS PubMed Google Scholar
• Pai, M., Minion, J., Steingart, K. & Ramsay, A. New and improved tuberculosis diagnostics: evidence, policy, practice, and impact. Curr. Opin. Pulm. Med. 16, 271–284 (2010).
  PubMed Google Scholar
• WHO. The global plan to stop TB 2011–2015: transforming the fight towards elimination of tuberculosis. (WHO, Geneva, 2010).
• Nathanson, C. M. et al. The TDR Tuberculosis Specimen Bank: a resource for diagnostic test developers. Int. J. Tuberc. Lung Dis. 14, 1461–1467 (2010).
  PubMed Google Scholar